Inhibikase Therapeutics, Inc. Common Stock IKT

$2.41 +0.00% at last close

Analyst Consensus

Consensus Rating
Buy (5 Buy · 0 Hold · 0 Sell)
Average Price Target
$5.40
Implied Upside
+124.1%
Price Target Range
$4.00 – $8.00
Analysts (12 mo)
5

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-06-10
Oppenheimer
Initiates coverage on Outperform $5
2026-03-04
Ladenburg ThalmannAydin Huseynov
Initiates coverage on Buy $4
2026-01-21
B of A SecuritiesJason Zemansky
Initiates coverage on Buy $6
2025-12-26
HC Wainwright & Co.Raghuram Selvaraju
Assumes Buy $8
2025-12-11
Cantor FitzgeraldOlivia Brayer
Initiates coverage on Overweight $4
2025-03-28
HC Wainwright & Co.Edward White
Reiterates Neutral
2025-02-12
HC Wainwright & Co.Edward White
Downgrades Buy → Neutral
2024-11-08
JefferiesDennis Ding
Initiates coverage on Buy $8
2024-10-14
HC Wainwright & Co.Edward White
Maintains Buy $15 → $5
2024-08-16
HC Wainwright & Co.Edward White
Maintains Buy $23 → $15
2024-05-21
HC Wainwright & Co.Edward White
Maintains Buy $27 → $23
2024-03-07
HC Wainwright & Co.Edward White
Reiterates Buy $27
2024-03-05
HC Wainwright & Co.Edward White
Maintains Buy $27
2023-08-15
HC Wainwright & Co.Edward White
Reiterates Buy $27
2023-06-30
HC Wainwright & Co.Edward White
Maintains Buy $5 → $27
2023-06-22
HC Wainwright & Co.Edward White
Reiterates Buy $30
2023-04-18
HC Wainwright & Co.Edward White
Initiates coverage on Buy $30
2022-11-16
JonesTradingSoumit Roy
Downgrades Buy → Hold
2021-07-15
JonesTradingSoumit Roy
Initiates coverage on Buy $72

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$2.41
Market Cap
$336.28 million
52-Week Range
$1.33 $2.53
Average Volume
860K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.